Bausch Health Companies (BHC) Income towards Parent Company (2009 - 2026)

Bausch Health Companies (BHC) reported Income towards Parent Company of -$1.4 billion for Q1 2026, down 1563.95% on a YoY basis from $97.7 million in Q1 2025, and down 1289.32% sequentially from -$103.0 million in Q4 2025.

Bausch Health Companies (BHC) Income towards Parent Company (2009 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 18 years of Income towards Parent Company data on file, last reported at -$1.4 billion in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company fell 1563.95% year-over-year to -$1.4 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.2 billion (down 1412.35% YoY), and the FY2025 full-year result was $120.0 million, up 266.67% from the prior year.
  • Income towards Parent Company slipped to -$1.4 billion in Q1 2026, from -$103.0 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $403.0 million in Q3 2022 to a low of -$1.4 billion in Q1 2026.
  • A 5-year average of -$129.8 million and a median of -$77.0 million in 2024 frame the typical range for Income towards Parent Company.
  • Across the five-year window, Income towards Parent Company soared 12900.0% in 2025 and plunged 1563.95% in 2026, its largest moves.
  • Tracing BHC's Income towards Parent Company over 5 years: stood at -$410.0 million in 2022, then surged by 88.54% to -$47.0 million in 2023, then soared by 308.51% to $98.0 million in 2024, then slumped by 205.1% to -$103.0 million in 2025, then plunged by 1289.32% to -$1.4 billion in 2026.
  • Business Quant data shows BHC's Income towards Parent Company at -$1.4 billion in Q1 2026, -$103.0 million in Q4 2025, and $181.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Bausch Health Companies 1.68 Bn 367.46 Mn 2.52 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.43 Bn
Dec 31, 2025 -103.00 Mn
Sep 30, 2025 181.00 Mn
Jun 30, 2025 128.00 Mn
Mar 31, 2025 -86.00 Mn
Dec 31, 2024 98.00 Mn
Sep 30, 2024 -92.00 Mn
Jun 30, 2024 -1.00 Mn
Mar 31, 2024 -77.00 Mn
Dec 31, 2023 -47.00 Mn
Sep 30, 2023 -382.00 Mn
Jun 30, 2023 27.00 Mn
Mar 31, 2023 -209.00 Mn
Dec 31, 2022 -410.00 Mn
Sep 30, 2022 403.00 Mn
Jun 30, 2022 -139.00 Mn
Mar 31, 2022 -66.00 Mn
Dec 31, 2021 72.00 Mn
Sep 30, 2021 191.00 Mn
Jun 30, 2021 -593.00 Mn